Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
86.67
-0.15 (-0.17%)
At close: May 27, 2026, 4:00 PM EDT
86.67
0.00 (0.00%)
After-hours: May 27, 2026, 6:47 PM EDT
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $4.74 billion as of May 27, 2026. Its market cap has increased by 652.83% in one year.
Market Cap
4.74B
Enterprise Value
3.51B
1-Year Change
652.83%
Ranking
Category
Stock Price
$86.67
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $4.74B, an increase of 2,806.80%. That is a compound annual growth rate of 247.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 4.75B | 168.61% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cogent Biosciences | 5.58B |
| TG Therapeutics | 5.51B |
| Legend Biotech | 5.46B |
| Belite Bio | 5.40B |
| Xenon Pharmaceuticals | 5.24B |
| CRISPR Therapeutics AG | 4.86B |
| Ligand Pharmaceuticals | 4.60B |
| Caris Life Sciences | 4.40B |